| Clinicopathological parameters | Values | p-Value | ER/PR expression | Positive | Negative |
| Age (years), Mean ± SD | 53.17 ± 13.16 | 51.70 ± 11.73 | 0.504 | Age group | ≤35 years, n (%) | 2 (4.3) | 14 (14.9) | 0.181 | 36–50 years, n (%) | 18 (39.1) | 34 (36.2) | >50 years, n (%) | 26 (56.5) | 46 (48.9) | Follow-up duration (months), Mean ± SD | 4.52 ± 1.88 | 3.95 ± 1.86 | 0.096 | Tumor laterality | Right breast, n (%) | 20 (43.5) | 58 (61.7) | 0.041 | Left breast, n (%) | 26 (56.5) | 36 (38.3) | Tumor size (cm), n = 92 | 4.20 ± 1.88 | 6.62 ± 3.43 | 0.003 | Tumor (T) stage, n = 92 | T1, n (%) | 4 (16.7) | 8 (11.8) | <0.001 | T2, n (%) | 16 (66.7) | 18 (26.5) | T3, n (%) | 4 (16.7) | 42 (61.8) | Tumor grade | Grade 2, n (%) | 20 (43.5) | 14 (14.9) | <0.001 | Grade 3, n (%) | 26 (56.5) | 80 (85.1) | Squamous differentiation | Present, n (%) | 30 (65.2) | 66 (70.2) | 0.550 | Absent, n (%) | 16 (34.8) | 28 (29.8) | Chondroid differentiation | Present, n (%) | 4 (8.7) | 4 (4.3) | 0.439 | Absent, n (%) | 42 (91.3) | 90 (95.7) | Spindle cell differentiation | Present, n (%) | 4 (8.7) | 12 (12.8) | 0.477 | Absent, n (%) | 42 (91.3) | 82 (87.2) | Nodal (N) stage, n = 92, n (%) | N0, n (%) | 14 (58.3) | 38 (55.9) | 0.107 | N1, n (%) | 4 (16.7) | 14 (20.8) | N2, n (%) | 5 (20.8) | 4 (5.9) | N3, n (%) | 1 (4.2) | 12 (17.6) | Recurrence, n (%) | Yes, n (%) | 20 (43.5) | 24 (25.5) | 0.032 | No, n (%) | 26 (56.5) | 70 (74.5) | Survival status, n (%) | Alive, n (%) | 34 (73.9) | 66 (70.2) | 0.649 | Expired, n (%) | 12 (26.1) | 28 (29.8) |
|
|